The DOI matches its Crossref record.
Impact of Types of Lymphocyte Chromosomal Aberrations on Human Cancer Risk
Abstract
The frequency of cells with structural chromosomal aberrations (CAs) in peripheral blood lymphocytes is the first genotoxicity biomarker that has shown an association with cancer risk. CAs are usually divided into chromosome-type (CSAs) and chromatid-type aberrations (CTAs), with different mechanisms of formation. From a mechanistic point of view, it is of interest to clarify whether the cancer predictivity of CAs is different with respect to CSAs and CTAs. We report here cancer risk for cytogenetically tested, healthy subjects with respect to frequency of CAs, CSAs, and CTAs in peripheral blood lymphocytes, using Nordic (1981 subjects with CA data, 1871 subjects with CSA/CTA data) and Italian (1573 subjects with CA data, 877 subjects with CTA/CSA data) cohorts, with a median follow-up of 17 years. High levels of CAs at test were clearly associated with increased total cancer incidence in the Nordic cohorts and increased total cancer mortality in the Italian cohort. In the Nordic cohorts, significantly elevated cancer risks were observed for subjects with both high CSAs and high CTAs at test, and these variables showed equally strong cancer predictivity. The results of the Italian cohort did not indicate any clear-cut difference in cancer predictivity between the CSA and CTA biomarkers. There was no significant effect modification by age at test, gender, country, or time since test. The results suggest that both DNA double-strand breaks and other initial DNA lesions responsible for CSAs and CTAs are associated with cancer risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bonassi, S., Znaor, A., Ceppi, M., Lando, C., Chang, W. P., Holland, N., Kirsch-Volders, M., Zeiger, E., Ban, S., Barale, R., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl177 · Cited by 1,023
Self-citationHOLLAND, N., BOLOGNESI, C., KIRSCHVOLDERS, M., BONASSI, S., ZEIGER, E., KNASMUELLER, S., & FENECH, M. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.03.007 · Cited by 600
Self-citationMicronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies
Bonassi, S., El-Zein, R., Bolognesi, C., & Fenech, M. (2011) · Mutagenesis · doi:10.1093/mutage/geq075 · Cited by 471
Self-citationThe Comet assay for the evaluation of genotoxic impact in aquatic environments
FRENZILLI, G., NIGRO, M., & LYONS, B. (2009) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.03.001 · Cited by 410
Chromosomal changes: induction, detection methods and applicability in human biomonitoring
Mateuca, R., Lombaert, N., Aka, P. V., Decordier, I., & Kirsch-Volders, M. (2006) · Biochimie · doi:10.1016/j.biochi.2006.07.004 · Cited by 367
Metadata
- Authors
- Hagmar, L., Strömberg, U., Bonassi, S., Hansteen, I.-L., Knudsen, L. E., Lindholm, C., & Norppa, H.
- Venue
- Cancer Research
- Published
- 2004-03-15
- Volume
- 64
- Issue
- 6
- Pages
- 2258-2263
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2151867783
- Cited by
- 224
- References
- 0
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of Types of Lymphocyte Chromosomal Aberrations on Human Cancer Risk. https://app.cochat.ai/papers/10.1158/0008-5472.can-03-3360
- The paper
- Hagmar, L., Strömberg, U., Bonassi, S., Hansteen, I.-L., Knudsen, L. E., Lindholm, C., & Norppa, H. (2004). Impact of Types of Lymphocyte Chromosomal Aberrations on Human Cancer Risk. Cancer Research. https://doi.org/10.1158/0008-5472.can-03-3360
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.